Home » Topics » Regulatory

Regulatory
RSS

GSK's four-strain seasonal influenza vaccine Fluarix Quadrivalent approved for use in U.S.

Dec. 18, 2012

No Comments

FDA approves GSK's raxibacumab for inhalational anthrax

Dec. 17, 2012

No Comments

FDA expands indication for Zytiga

Dec. 12, 2012

No Comments

FDA approves Cometriq, EMA accepts MAA

Nov. 30, 2012

No Comments

FDA approves Zilver PTX drug-eluting stent for peripheral arterial disease

Nov. 16, 2012

No Comments

Bristol-Myers Squibb and AstraZeneca gain European approval for dapagliflozin

Nov. 15, 2012

No Comments

FDA approves Pfizer's Xeljanz for rheumatoid arthritis

Nov. 8, 2012

No Comments

Glybera gene therapy approved by the European Commission

Nov. 5, 2012

No Comments

FDA grants first approval to ocriplasmin

Oct. 18, 2012

No Comments

FDA approves Abraxane for NSCLC

Oct. 15, 2012

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

GSK's four-strain seasonal influenza vaccine Fluarix Quadrivalent approved for use in U.S.

FDA approves GSK's raxibacumab for inhalational anthrax

FDA expands indication for Zytiga

FDA approves Cometriq, EMA accepts MAA

FDA approves Zilver PTX drug-eluting stent for peripheral arterial disease

Bristol-Myers Squibb and AstraZeneca gain European approval for dapagliflozin

FDA approves Pfizer's Xeljanz for rheumatoid arthritis

Glybera gene therapy approved by the European Commission

FDA grants first approval to ocriplasmin

FDA approves Abraxane for NSCLC

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Regulatory RSS

Regulatory
RSS